Syntheses, cytotoxic activity evaluation and HQSAR study of 1,2,3-triazole-linked isosteviol derivatives as potential anticancer agents

[Display omitted] •A series of novel 1,2,3-triazole-linked isosteviol derivatives were synthesized.•Their cytotoxicities were assessed against HCT-116 and JEKO-1cell lines.•Compound 10b is promising anticancer agent against HCT-116 (IC50=2.987±0.098μM).•HQSAR studies revealed good predictive model....

Full description

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry letters Vol. 26; no. 22; pp. 5455 - 5461
Main Authors Liu, Cong-Jun, Liu, Yan-Ping, Yu, Shu-Ling, Dai, Xing-Jie, Zhang, Tao, Tao, Jing-Chao
Format Journal Article
LanguageEnglish
Published OXFORD Elsevier Ltd 15.11.2016
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:[Display omitted] •A series of novel 1,2,3-triazole-linked isosteviol derivatives were synthesized.•Their cytotoxicities were assessed against HCT-116 and JEKO-1cell lines.•Compound 10b is promising anticancer agent against HCT-116 (IC50=2.987±0.098μM).•HQSAR studies revealed good predictive model. A series of novel 1,2,3-triazole-linked isosteviol derivatives were designed and synthesized via Huisgen-click reaction. Their cytotoxicities in vitro against HCT-116 and JEKO-1 cells were screened. The preliminary bioassays indicated that most of the title compounds exhibited noteworthy cytotoxic activities. Particularly, the compound 10b revealed the most potent inhibitory activities against HCT-116 cells with IC50 value of 2.987±0.098μM, which was better than that (3.906±0.261μM) of positive control cisplatin. On the basis of these bioactivity data, hologram quantitative structure–activity relationship (HQSAR) was performed, and a statistically reliable model with good predictive power (r2=0.848, q2=0.544 and R2pred=0.982) was achieved. Additionally, the contribution maps derived from the optimal model explained the individual atomic contributions to the activity for each molecule.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2016.10.028